Comparison of Survival Rates Based on Recommended Treatment Algorithms of BCLC or HKLC Staging Systems for Hepatocellar Carcinoma Patients

Comparison of Survival Rates Based on Recommended Treatment Algorithms of BCLC or HKLC Staging Systems for Hepatocellar Carcinoma Patients

Objective To evaluate the effect of the recommended treatment algorithms of the Barcelona Clinic Liver Cancer (BCLC) or Hong Kong Liver Cancer (HKLC) staging systems on the survival rate of patients with HCC. Methods A total of 436 patients newly diagnosed as HCC were analyzed. The prognostic perfor...

Full description

Bibliographic Details
Main Authors:	DENG Guoyu, CHEN Jie, HUANG Shan, LI Kezhi, HE Jianbo, WU Guobin, CHEN Chuang
Format:	Article
Language:	zho
Published:	Magazine House of Cancer Research on Prevention and Treatment 2019-04-01
Series:	Zhongliu Fangzhi Yanjiu
Subjects:	primary liver cancer hepatocellular carcinoma barcelona clinic liver cancer staging hong kong liver cancer staging prognosis
Online Access:	http://html.rhhz.net/ZLFZYJ/html/8578.2019.18.1340.htm

Similar Items

The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: basing on competing risk model
by: Huiwen Yan, et al.
Published: (2022-02-01)

Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System
by: Wee IJY, et al.
Published: (2022-08-01)

Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm
by: Mandy Richani, et al.
Published: (2016-01-01)

Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma
by: Chia-Yang Hsu, et al.
Published: (2018-03-01)

Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
by: Claudia Campani, et al.
Published: (2021-03-01)

Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2)
by: Masatoshi Kudo, et al.
Published: (2021-07-01)

Stereotactic Body Radiation Therapy vs. Transarterial Chemoembolization in Inoperable Barcelona Clinic Liver Cancer Stage a Hepatocellular Carcinoma: A Retrospective, Propensity-Matched Analysis
by: Ting-Shi Su, et al.
Published: (2020-03-01)

Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage
by: Luciana Kikuchi, et al.

The impact of general anesthesia on radiofrequency ablation of hepatocellular carcinoma
by: Yuan-Hung Kuo, et al.
Published: (2014-11-01)

Long-Term Survival in Patients Receiving Combination Therapy with Resection and Radiofrequency Ablation for Multi-Focal Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B: A Retrospective Controlled Study
by: Yan J, et al.
Published: (2020-04-01)

Transarterial chemoembolization for advanced hepatocellular carcinoma without macrovascular invasion or extrahepatic metastasis: analysis of factors prognostic of clinical outcomes
by: Ji Hoon Kim, et al.
Published: (2023-06-01)

Comparison of post-resection survival between hepatocellular carcinoma patients in BCLC stage A or B who experience tumor rupture and patients in BCLC stage C who do not
by: Su Jia-Yong, et al.
Published: (2024-03-01)

Outcome of transarterial radioembolization in patients with hepatocellular carcinoma as a first-line interventional therapy and after a previous transarterial chemoembolization
by: Julia Wagenpfeil, et al.
Published: (2024-02-01)

Changes in Presentation, Treatment, and Survival of Patients with Hepatocellular Carcinoma in Damietta, Egypt, 2007–2019: A Retrospective Monocentric Cohort Study
by: Jean K, et al.
Published: (2023-01-01)

Identification of the Microbiome Associated with Prognosis in Patients with Chronic Liver Disease
by: Kenta Yamamoto, et al.
Published: (2024-03-01)

A proposed five-step simplified algorithm for the management of hepatocellular carcinoma in India
by: Anil Arora, et al.
Published: (2022-01-01)

A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy
by: Yang-Xun Pan, et al.
Published: (2019-10-01)

Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis
by: Chih-Wen Lin, et al.
Published: (2020-04-01)

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective
by: Tung-Hung Su, et al.
Published: (2023-04-01)

The priority of liver resection compared with transarterial chemoembolization in hepatocellular carcinoma at BCLC B1 stage: A single-center experience
by: Peng-Sheng Yi, et al.
Published: (2022-11-01)

Surgical Resection Is Superior to TACE in the Treatment of HCC in a Well Selected Cohort of BCLC-B Elderly Patients—A Retrospective Observational Study
by: Stefania Brozzetti, et al.
Published: (2022-09-01)

Diagnosis, staging and treatment of hepatocellular carcinoma
by: A.V.C. França, et al.
Published: (2004-11-01)

Individualized Selection Criteria Based on Tumor Burden in Future Remnant Liver for Staged Hepatectomy of Advanced CRLM: Conventional TSH or ALPPS
by: Kun-Ming Chan, et al.
Published: (2022-07-01)

Radiation Segmentectomy for Hepatocellular Carcinoma
by: Muhamad Serhal, et al.
Published: (2024-01-01)

Efficacy of Combined Therapy with Drug-Eluting Beads-Transcatheter Arterial Chemoembolization Followed by Conventional Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multi-Center Study
by: Asahiro Morishita, et al.
Published: (2021-09-01)

Diagnostic accuracy of contrast-enhanced diffusion-weighted MRI for liver metastases of pancreatic cancer: towards adequate staging and follow-up of pancreatic cancer – DIA-PANC study: study protocol for an international, multicenter, diagnostic trial
by: G. Litjens, et al.
Published: (2020-08-01)

Hepatocellular Carcinoma: A Review
by: Tarana Gupta
Published: (2020-09-01)

Disparities in stage at diagnosis for liver cancer in China
by: Tianhao Shan, et al.
Published: (2023-03-01)

Social life and development in Hong Kong/
by: King, Ambrose Y. C., et al.
Published: (1981)

Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy
by: Luca Ielasi, et al.
Published: (2024-01-01)

Atezolizumab and Bevacizumab Combination Therapy in the Treatment of Advanced Hepatocellular Cancer
by: Ignacio Ventura, et al.
Published: (2023-12-01)

Hong Kong's transitions, 1842-1997 /
by: Brown, Judith M., et al.
Published: (1997)

Lymph node ratio as a valuable prognostic factor for patients with colorectal liver-only metastasis undergoing curative resection
by: Deng YX, et al.
Published: (2018-07-01)

Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio
by: Linda Wong, et al.
Published: (2019-09-01)

Editorial: The tumor microenvironment and malignant properties in primary liver cancer
by: Chen Qu
Published: (2023-08-01)

Midnolin Regulates Liver Cancer Cell Growth In Vitro and In Vivo
by: Soo-Mi Kweon, et al.
Published: (2022-03-01)

Seeing red : China's uncompromising takeover of Hong Kong /
by: 289467 Allen, Jamie
Published: (1997)

Hong Kong China : the red dawn /
by: Yeung, Chris, 1958-
Published: (1998)

Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies
by: Md. Mohaimenul Islam, et al.
Published: (2020-03-01)

Long‐term outcomes of staged liver resection for synchronous liver metastases from colorectal cancer and the clinical impact of early recurrence: A single‐center retrospective cohort study
by: Shunsuke Kasai, et al.
Published: (2023-03-01)